ctx-8371
ctx-8371: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Compass Therapeutics, Inc. (CMPX) | Phase 1 |
Get deeper analysis on ctx-8371
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis